MedicineInfectious DiseasesInflammationInnate ImmunityPulmonologyPulmonary InfectionsPulmonary PathologyRespiratory DiseaseRespiratory InfectionsRespiratory PathologyRespiratory PathophysiologyBronchoalveolar Lavage AnalysisPhospholipase-mediated Lipid ReleasePhospholipid ContentPhospholipid TurnoverPneumocystis InfectionPulmonary PathogenesisPulmonary Surfactant PhysiologySurfactant Function
Respiratory distress, main clinical symptom of P. carinii pneumonia, is unexplained. We wondered if it could be linked with a lung surfactant anomaly. We have shown in the bronchoalveolar fluid lavage of P. carinii-infected rats: a very significant decrease of the phospholipid content; a lowering of the phospholipid/protein ratio; and an increase in phospholipase activities, partly due to the activation of an inactive phospholipase into the active form. We conclude that, in P. carinii-infected rats, there is an increased catabolism of lung surfactant.
7
<i>Pneumocystis carinii</i>Pneumonia
Walter T. Hughes · New England Journal of Medicine · 1977 · 110 citations
Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
Paul N. Lanken, Melanie Minda, Giuseppe G. Pietra et al. · PubMed · 1980 · 76 citations